Cargando…
Comparison of Oral and Intravenous N-acetyl Cysteine in Preventing Contrast Nephropathy
INTRODUCTION: Despite high rates of morbidity and mortality in patients with contrast-induced nephropathy (CIN), there is no consensus regarding prevention of this well-known complication of contrast media use. One agent that has been widely used in this regard is N-acetyl cysteine (NAC). Neverthele...
Autores principales: | Khatami, Mohammad Reza, Nikravan, Nasrin, Salarifar, Mojtaba, Poorhosseini, Hamid Reza, Sadeghian, Saeid, Haj-Zeinali, Ali Mohammad, Aghajani, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023025/ https://www.ncbi.nlm.nih.gov/pubmed/33840960 http://dx.doi.org/10.4103/ijn.IJN_260_19 |
Ejemplares similares
-
Predictors of in-hospital mortality in diabetic patients with non-ST-elevation myocardial infarction
por: Ghorashi, Seyyed Mojtaba, et al.
Publicado: (2022) -
Effect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CT
por: Momeni, Ali, et al.
Publicado: (2012) -
The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy
por: Khatami, M. R., et al.
Publicado: (2015) -
Suppression of cirrhosis-related renal injury by N-acetyl cysteine
por: Abdoli, Narges, et al.
Publicado: (2020) -
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
por: Poorhosseini, Hamid Reza, et al.
Publicado: (2012)